Effect of hyperthermia on liver cell lines: Important findings for thermal therapy in hepatocellular carcinoma

Anticancer Research

Volumn 31, Issue 5, 2011, Pages 1583-1588

  Mayrhauser, Ursula ^a   Stiegler, Philipp ^a   Stadlbauer, Vanessa ^b   Koestenbauer, Sonja ^a   Leber, Bettina ^a   Konrad, Katja ^a   Iberer, Florian ^a   Portugaller, Rupert Horst ^a   Tscheliessnigg, Karlheinz ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Fibrosis; HCC; Hepatic stellate cells; HepG2; Hyperthermia; Thermal cancer therapy

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CANCER REHABILITATION; CELL DEATH; CELL METABOLISM; CELL STRAIN HEPG2; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; THERMAL EXPOSURE;

CARCINOMA, HEPATOCELLULAR; COCULTURE TECHNIQUES; FEVER; HOT TEMPERATURE; HUMANS; LIVER; LIVER NEOPLASMS; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 79958152279     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007. (Pubitemid 46890874)
2. Llovet JM, Schwartz M and Mazzaferro V: Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25: 181-200, 2005. (Pubitemid 40781071)
3. Petrowsky H and Busuttil RW: Evolving surgical approaches in liver transplantation. Semin Liver Dis 29: 121-133, 2009.
4. Lin DY, Lin SM and Liaw YF: Non-surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 12: S319-28, 1997.
5. Shiina S, Teratani T, Obi S, Hamamura K, Koike Y and Omata M: Nonsurgical treatment of hepatocellular carcinoma: From percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 62(Suppl 1): 64-68, 2002. (Pubitemid 34702022)
6. Livraghi T: Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma. J Hepatobiliary Pancreat 10: 67-76, 2003.
7. Gaiani S, Celli N, Cecilioni L, Piscaglia F and Bolondi L: Review article: Percutaneous treatment of hepatocellular carcinoma. Aliment Pharmacol Ther 17(Suppl 2): 103-110, 2003. (Pubitemid 36831467)
8. Llovet JM and Bruix J: Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48(Suppl 1): S20-37, 2008.
9. Poggi G, Gatti C, Teragni C, Delmonte A and Bernardo G: Radiofrequency ablation combined with percutaneous ethanol injection in the treatment of hepatocellular carcinoma and portal vein neoplastic thrombosis. Anticancer Res 24: 2419-2421, 2004.
10. Ritz JP, Lehmann KS, Zurbuchen U, Wacker F, Brehm F, Isbert C, Germer CT, Buhr HJ and Holmer C: Improving laser-induced thermotherapy of liver metastases-effects of arterial microembolization and complete blood flow occlusion. Eur J Surg Oncol 33: 608-615, 2007. (Pubitemid 46758869)
11. Vanagas T, Gulbinas A, Pundzius J and Barauskas G: Radiofrequency ablation of liver tumors (I): Biological background. Medicina (Kaunas) 46: 13-17, 2010.
12. Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669, 2008.
13. Henderson NC and Forbes SJ: Hepatic fibrogenesis: From within and outwith. Toxicology 254: 130-135, 2008.
14. Cardinal J, Klune JR, Chory E, Jeyabalan G, Kanzius JS, Nalesnik M and Geller DA: Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles. Surgery 144: 125-132, 2008. (Pubitemid 352010312)
15. Ypsilantis P, Panopoulou M, Lambropoulou M, Tsigalou C, Pitiakoudis M, Tentes I, Kartali S, Papachristou F, Papadopoulos N and Simopoulos C: Bacterial translocation in a rat model of large volume hepatic radiofrequency ablation. J Surg Res 161: 250-258, 2010.
16. Yoshimoto T, Kotoh K, Horikawa Y, Kohjima M, Morizono S, Yamashita S, Enjoji M and Nakamuta M: Decreased portal flow volume increases the area of necrosis caused by radio frequency ablation in pigs. Liver Int 27: 368-372, 2007. (Pubitemid 46416628)
17. Liu Z, Ahmed M, Weinstein Y, Yi M, Mahajan RL and Goldberg SN: Characterization of the RF ablation-induced 'oven effect': The importance of background tissue thermal conductivity on tissue heating. Int J Hyperthermia 22: 327-342, 2006. (Pubitemid 43878855)
18. Xu L, Hui AY, Albanis E, Arthur MJ, O'Byrne SM, Blaner WS, Mukherjee P, Friedman SL and Eng FJ: Human hepatic stellate cell lines, LX-1 and LX-2: New tools for analysis of hepatic fibrosis. Gut 54: 142-151, 2005.
19. Hui AY, Dannenberg AJ, Sung JJ, Subbaramaiah K, Du B, Olinga P and Friedman SL: Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells. J Hepatol 41: 251-258, 2004. (Pubitemid 39177629)
20. Lepock JR: How do cells respond to their thermal environment? Int J Hyperthermia 21: 681-687, 2005.
21. Obara K, Matsumoto N, Okamoto M, Kobayashi M, Ikeda H, Takahashi H, Katakura Y, Matsunaga K, Ishii T, Okuse C, Suzuki M and Itoh F: Insufficient radiofrequency ablation therapy may induce further malignant transformation of hepatocellular carcinoma. Hepatol Int 2: 116-123, 2008. (Pubitemid 351250411)
22. O'Neill DP, Peng T, Stiegler P, Mayrhauser U, Koestenbauer S, Tscheliessnigg K and Payne SJ: A three-state mathematical model of hyperthermic cell death. Ann Biomed Eng 39: 570-579, 2011.
23. Amann T, Bataille F, Spruss T, Muhlbauer M, Gabele E, Scholmerich J, Kiefer P, Bosserhoff AK and Hellerbrand C: Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 100: 646-653, 2009.